Luwen Shi

2.1k total citations
106 papers, 1.3k citations indexed

About

Luwen Shi is a scholar working on Economics and Econometrics, General Health Professions and Applied Microbiology and Biotechnology. According to data from OpenAlex, Luwen Shi has authored 106 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Economics and Econometrics, 20 papers in General Health Professions and 17 papers in Applied Microbiology and Biotechnology. Recurrent topics in Luwen Shi's work include Pharmaceutical Economics and Policy (20 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Antibiotic Use and Resistance (17 papers). Luwen Shi is often cited by papers focused on Pharmaceutical Economics and Policy (20 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers) and Antibiotic Use and Resistance (17 papers). Luwen Shi collaborates with scholars based in China, United States and Canada. Luwen Shi's co-authors include Xiaodong Guan, Haishaerjiang Wushouer, Sheng Han, Huigang Liang, Shanshan Wu, Feng Sun, Zhirong Yang, Yuan Zhang, Kai Yu and Yajiong Xue and has published in prestigious journals such as Nature Medicine, PLoS ONE and Neurology.

In The Last Decade

Luwen Shi

95 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luwen Shi China 20 318 240 185 163 162 106 1.3k
Minghuan Jiang China 19 311 1.0× 92 0.4× 179 1.0× 166 1.0× 174 1.1× 61 1.1k
Shuang Hu China 22 292 0.9× 117 0.5× 425 2.3× 425 2.6× 187 1.2× 86 2.1k
Inmaculada Hernandez United States 26 632 2.0× 270 1.1× 224 1.2× 15 0.1× 189 1.2× 147 2.6k
Karolina Andersson Sundell Sweden 25 632 2.0× 144 0.6× 164 0.9× 21 0.1× 314 1.9× 74 1.7k
Subish Palaian Nepal 26 373 1.2× 171 0.7× 239 1.3× 23 0.1× 391 2.4× 192 2.2k
Alian A. Alrasheedy Saudi Arabia 23 426 1.3× 118 0.5× 244 1.3× 27 0.2× 265 1.6× 76 1.4k
Yu Ko Taiwan 27 278 0.9× 352 1.5× 270 1.5× 28 0.2× 181 1.1× 86 1.8k
Katie MacLure United Kingdom 25 134 0.4× 48 0.2× 676 3.7× 53 0.3× 63 0.4× 72 1.8k
Imran Masood Pakistan 19 168 0.5× 57 0.2× 115 0.6× 21 0.1× 126 0.8× 81 1.2k
Linda E. Lévesque Canada 24 251 0.8× 364 1.5× 198 1.1× 19 0.1× 129 0.8× 50 3.1k

Countries citing papers authored by Luwen Shi

Since Specialization
Citations

This map shows the geographic impact of Luwen Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwen Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwen Shi more than expected).

Fields of papers citing papers by Luwen Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwen Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwen Shi. The network helps show where Luwen Shi may publish in the future.

Co-authorship network of co-authors of Luwen Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Luwen Shi. A scholar is included among the top collaborators of Luwen Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwen Shi. Luwen Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Shujie, Tiansheng Wang, Jingkai Wei, et al.. (2025). Statin Use and Risk of Intracerebral Hemorrhage in Chinese Population. Neurology. 104(8). e213489–e213489. 1 indexed citations
2.
Bai, Lin, et al.. (2025). Medicine availability and affordability for paediatric cancers, China. Bulletin of the World Health Organization. 103(1). 19–31B.
3.
4.
5.
Zhang, Yi, Lan Zhang, Yichen Zhang, et al.. (2024). Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysis. EClinicalMedicine. 71. 102561–102561. 12 indexed citations
6.
7.
Ma, Zhuo, Man Xu, Tao Huang, et al.. (2024). Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer. BMC Geriatrics. 24(1). 550–550. 1 indexed citations
8.
9.
Dong, Wen‐Liang, Xiaowen Hu, Caiying Wu, et al.. (2023). Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 63. 152302–152302. 1 indexed citations
10.
Gong, Zhiwen, et al.. (2023). Appropriate use of antibiotics for acute respiratory infections at primary healthcare facilities in China: a nationwide cross-sectional study from 2017 to 2019. The Lancet Regional Health - Western Pacific. 40. 100880–100880. 10 indexed citations
11.
12.
Hu, Lin, et al.. (2022). The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China. Frontiers in Public Health. 10. 936719–936719. 9 indexed citations
13.
Li, Xiaoxiao, Guanru Wang, Na He, et al.. (2022). Severe Thrombocytopenia Caused by Vancomycin in the Intensive Care Unit: A Case Report. Frontiers in Medicine. 9. 829267–829267. 2 indexed citations
14.
Chen, Ta-Liang, et al.. (2020). Prevalence, expenditures, and associated factors of purchasing non-prescribed Chinese herbal medicine in Taiwan. PLoS ONE. 15(10). e0240311–e0240311. 7 indexed citations
15.
Li, Xiaoxiao, Siqian Zheng, Tao Huang, et al.. (2020). Drug-Related Problems Identified During Pharmacy Intervention and Consultation: Implementation of an Intensive Care Unit Pharmaceutical Care Model. Frontiers in Pharmacology. 11. 571906–571906. 18 indexed citations
16.
Hu, Hao, Xiaodong Guan, Carolina Oi Lam Ung, et al.. (2018). Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease. Chinese Medicine. 13(1). 28–28. 14 indexed citations
17.
Liang, Huigang, et al.. (2013). Can Price Controls Reduce Pharmaceutical Expenses? A Case Study of Antibacterial Expenditures in 12 Chinese Hospitals from 1996 to 2005. International Journal of Health Services. 43(1). 91–103. 20 indexed citations
18.
Sun, Feng, Kai Yu, Zhirong Yang, et al.. (2012). Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis. Experimental Diabetes Research. 2012. 1–14. 45 indexed citations
19.
Shi, Luwen. (2009). Analysis of the protection to marketing approval data under the TRIPS Agreement. Zhongguo xin yao zazhi. 1 indexed citations
20.
Shi, Luwen. (2008). Analysis of the impact factors in development of Uyghur medicine industry by AHP-SWOT. Zhongguo xin yao zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghuan Jiang Breakdown of academic impact, for papers by Shuang Hu Breakdown of academic impact, for papers by Inmaculada Hernandez Breakdown of academic impact, for papers by Karolina Andersson Sundell Breakdown of academic impact, for papers by Subish Palaian Breakdown of academic impact, for papers by Alian A. Alrasheedy Breakdown of academic impact, for papers by Yu Ko Breakdown of academic impact, for papers by Katie MacLure Breakdown of academic impact, for papers by Imran Masood Breakdown of academic impact, for papers by Linda E. Lévesque
Rankless by CCL
2026